Statement From Secretary Sebelius on Reallocating $25 Million for AIDS Drug Assistance
July 9, 2010
The U.S. Department of Health and Human Services took an important step to improve access to critical HIV/AIDS prescription drugs. The $25 million reallocated for AIDS drug assistance provides resources to States that have AIDS Drug Assistance Program (ADAP) waiting lists or have implemented strategies to contain costs and delay or prevent a waiting list.
This week, we improved access to critical HIV/AIDS prescription drugs and are continuing to work towards preventing, and ultimately eliminating, the need for ADAP waiting lists. Governors will soon receive a letter detailing how to access these funds. The Administration has been steadily increasing funding and while this is a significant infusion of funds, on top of more than $800 million already specifically allocated to the ADAP Program this year, the Federal government cannot do this alone--States and Pharmaceutical companies also need to do their part.
Improving access to care and treatment for people living with HIV is a top priority for HHS. These funds are just one part of a broader effort we are making to improve the health status of people living with HIV. Created under the Affordable Care Act, the Pre-Existing Condition Insurance Plan will provide a new health coverage option for Americans who have been uninsured for at least six months and have been unable to get health coverage because of a health condition?including HIV. This option will be available until 2014, when insurers will be banned from discriminating against adults with pre-existing conditions.
For more information, see the fact sheet.
To learn more about the Pre-Existing Condition Insurance Plan, please visit: www.healthcare.gov/law/about/provisions/pcip/
To learn more about HIV, please visit www.AIDS.gov.
This article was provided by U.S. Department of Health and Human Services.
Add Your Comment:
Internet search results. Be careful when providing personal information! Before
adding your comment, please read TheBody.com's Comment Policy.)